Latest news and press releases about SANUWAVE Health Inc. (SNWV): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration.
Price
| Price | $4.43 |
| Market Cap | $38M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 2.47 |
| Price / Book | 12.75 |
| EV / EBITDA | 2.42 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 1728.10% |
| Return on Invested Capital | 2.80% |
| Return on Assets | 39.10% |
| Gross Margin | 75.20% |
| Operating Margin | 1.54% |
| Net Margin | 32.60% |
Related companies: FHTX · HSDT · IMRX · INGN · MASS · NNOX · OM
Explore sector: Healthcare · Medical - Devices
More sections of SNWV: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks